SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-195513
Filing Date
2012-04-30
Accepted
2012-04-30 15:03:45
Documents
11
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F d327204d20f.htm 20-F 1861696
2 SUBSIDIARIES OF REGISTRANT d327204dex81.htm EX-8.1 2133
3 CHIEF EXECUTIVE OFFICER CERTIFICATION PURSUANT TO SECTION 302 d327204dex121.htm EX-12.1 8560
4 CHIEF FINANCIAL OFFICER CERTIFICATION PURSUANT TO SECTION 302 d327204dex122.htm EX-12.2 8551
5 CHIEF EXECUTIVE OFFICER CERTIFICATION PURSUANT TO SECTION 906 d327204dex131.htm EX-13.1 3966
6 CHIEF FINANCIAL OFFICER CERTIFICATION PURSUANT TO SECTION 906 d327204dex132.htm EX-13.2 3966
7 CONSENT OF PRICEWATERHOUSECOOPERS ZHONG TIAN CPAS LIMITED COMPANY d327204dex151.htm EX-15.1 1568
8 CONSENT OF FANGDA PARTNERS d327204dex152.htm EX-15.2 2864
9 GRAPHIC g327204g73l68.jpg GRAPHIC 35057
10 GRAPHIC g327204g81n23.jpg GRAPHIC 37417
11 GRAPHIC g327204g98z22.jpg GRAPHIC 13451
  Complete submission text file 0001193125-12-195513.txt   2013242
Mailing Address NO. 5 BUILDING, 998 HALEI ROAD ZHANGJIANG HI-TECH PARK PUDONG NEW AREA SHANGHAI F4 201203
Business Address NO. 5 BUILDING, 998 HALEI ROAD ZHANGJIANG HI-TECH PARK PUDONG NEW AREA SHANGHAI F4 201203 (86-21) 5132-0088
ShangPharma Corp (Filer) CIK: 0001499470 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-34895 | Film No.: 12794453
SIC: 2834 Pharmaceutical Preparations